Fox Business on MSN
Pfizer wins 'fantastic deal' after $10B obesity drug fight with Novo Nordisk
Pfizer Chairman and CEO Albert Bourla joins 'Mornings with Maria' to discuss the company’s $10 billion acquisition of obesity ...
Jefferies London Healthcare Conference 2025 November 19, 2025 4:00 AM ESTCompany ParticipantsDavid Denton - Executive VP ...
Revised transaction values Metsera at up to $86.25 per share -- Metsera's Board of Directors unanimously recommends that Metsera stockholders approve the adoption of the amended Pfizer merger ...
Pfizer's Conor Riordan explains how the pharmaceutical giant uses Celonis across 200+ markets to drive toward 95% order ...
Revised transaction values Metsera at up to $86.25 per share Metsera's Board of Directors unanimously recommends that Metsera stockholders approve the adoption ...
17hon MSN
What's in the Epstein files and the deadly conditions for some pregnant prisoners: Morning Rundown
Documents scheduled to become public are from the FBI and the Justice Department's investigative files into Epstein and his ...
Pfizer Inc. (NYSE: PFE) today issued the following statement in response to the Delaware Chancery Court’s decision denying Pfizer’s request for a temporary restraining order to prevent Metsera, Inc.
Pfizer Inc. ( PFE) Discusses Clinical Development Strategy for 4404 Bispecific Antibody in Oncology November 10, 2025 8:30 AM EST ...
The article argues that the decline in public companies is due to private mergers, not regulation or litigation risks.
The Texas Tribune on MSN
A small Texas think tank cultivated COVID dissidents. Now they’re running U.S. health policy.
People with ties to Brownstone Institute have significant authority over access to vaccines and scientific research.
The revised bids are the latest unusual twist in the fight between big drugmakers over drug developer Metsera.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback